The Spanish company Laboratorios Cinfa  acquired Sakura Italia, with the aim to expand its presence on a major market for nutraceutical products. The deal will enrich Cinfa with a new portfolio of approx. 40 products in six therapeutic areas (gynecology, vascular system, immune system, digestive system, respiratory system and dermatology).  With more than a thousand employees, Cinfa is present in more than 55 countries. The Spanish company inveted € 65 milions in R&D in the last three years.